Psychiatr. praxi. 2016;17(1):25-27 | DOI: 10.36290/psy.2016.007

Use of atomoxetine in the treatment of adult ADHD - case study

MUDr. Bc. Daniela Zmeškalová, prof. MUDr. Ján Praško, CSc.
Klinika psychiatrie, Lékařská fakulta Univerzity Palackého v Olomouci, Fakultní nemocnice Olomouc

The case study describes a young adult woman coming to a psychiatric clinic primarily for problems with attention deficit. The patient is diagnosed with ADHD and started on non-stimulant medication atomoxetine, causing improvement in attention, impulsivity and hyperactivity leading to improvement in academic functioning and better time management.

Keywords: ADHD, adult ADHD, treatment, atomoxetine

Published: March 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zmeškalová D, Praško J. Use of atomoxetine in the treatment of adult ADHD - case study. Psychiatr. praxi. 2016;17(1):25-27. doi: 10.36290/psy.2016.007.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007; 190: 402-409. Go to original source... Go to PubMed...
    2. Raboch J, Hrdlička M, Mohr P. DSM-5. Diagnostický a statistický manuál duševních poruch. Testcentrum 2015.
    3. Garnock-Jones KP, Keating GM. Spotlight on atomoxetine in attention-deficit hyperactivity disorder in children and adolescents. CNS Drugs, 2010; 24: 85-88. Go to original source... Go to PubMed...
    4. Theiner P, Paclt I. ADHD u dospělých. In RABOCH, J., et al. Psychiatrie: doporučené postupy psychiatrické péče IV. 2014.
    5. Masopust J, Mohr P, Anders M, Přikryl R. Diagnostika a farmakoterapie ADHD v dospělosti. Psychiatrie pro praxi 2014; 15(3): 112-116.
    6. Clemow DB, Bushe CJ. Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients. Journal of Psychopharmacology 2015; 29(12): 1221-1230. Go to original source... Go to PubMed...
    7. SPC Strattera - http://www.sukl.cz/download/spc/SPC28190.pdf.
    8. FDA, Strattera, 2007 - http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021411s004s012s013s015s021lbl.pdf.
    9. Drtílková I, Hrdlička M, Paclt I. Hyperkinetické poruchy (ADHD) u dětí. In Raboch J, et al. Psychiatrie: Doporučené postupy psychiatrické péče IV. 2014.
    10. Sumner CR, Schuh KJ, Sutton VK, Lipetz R, Kelsey DK. Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis. J Child Adolesc Psychopharmacol. 2006; 16(6): 699-711. Go to original source... Go to PubMed...
    11. Dadashova R, Silverstone PH. Off-label use of atomoxetine in adults: is it safe? Mental Illness. 2012; 4(2): e19. doi:10.4081/mi.2012.e19. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.